Tango Therapeutics to Participate in Upcoming Investor Conferences
01 Março 2023 - 9:00AM
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage
biotechnology company committed to discovering and delivering the
next generation of precision cancer medicines, today announced that
Barbara Weber, M.D., President and Chief Executive Officer of Tango
Therapeutics, is scheduled to participate in the following upcoming
investor conferences in March.
Cowen 43rd Annual
Health Care Conference Date: Wednesday, March 8, 2023Time:
11:10 AM ETLocation: Boston, MA
Barclays Global Healthcare ConferenceDate:
Tuesday, March 14, 2023Time: 3:35 PM ETLocation: Miami, FL
A live webcast of the presentations will be available under the
"Events & Presentations" tab on the “Investors” page on the
Company's website on the day of the event. A replay of the webcasts
will be archived on the Company's website for 90 days following the
presentation.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company
dedicated to discovering novel drug targets and delivering the next
generation of precision medicine for the treatment of cancer. Using
an approach that starts and ends with patients, Tango leverages the
genetic principle of synthetic lethality to discover and develop
therapies that take aim at critical targets in cancer. This
includes expanding the universe of precision oncology targets into
novel areas such as tumor suppressor gene loss and their
contribution to the ability of cancer cells to evade immune cell
killing. For more information, please visit www.tangotx.com.
Investor Contact:Sam Martin/Andrew VulisArgot
Partnerstango@argotpartners.com
Media Contact:Joshua R. Mansbach Argot Partners
tango@argotpartners.com
Tango Therapeutics (NASDAQ:TNGX)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Tango Therapeutics (NASDAQ:TNGX)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024